Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effect of Gentamicin Intravesical Installations on Decreasing Urinary Tract Infections in Patients With Neurogenic Bladder After Spinal Cord Injury: A Clinical Trial

NCT03503513 is registered in ClinicalTrials.gov with University of Michigan as lead sponsor.

NCT NCT03503513
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03503513 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effect of Gentamicin Intravesical Installations on Decreasing Urinary Tract Infections in Patients With Neurogenic Bladder After Spinal Cord Injury: A Clinical Trial
Lead sponsor
University of Michigan
Phase
Phase 2/3
Overall status
Completed
Start date
August 24, 2018
Completion date
September 30, 2023
Enrollment
23 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

neurogenic bladder, spinal cord diseases, spinal cord injuries, urinary tract infections